Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years

M. R. McClung, A. Balske, D. E. Burgio, D. Wenderoth, R. R. Recker

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint Dive into the research topics of 'Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years'. Together they form a unique fingerprint.

Medicine & Life Sciences